Pfizer Inc., PFE is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Pfizer Inc., PFE has a market cap of 198635.51. Since its IPO date on the 6/1/1972, Pfizer Inc., PFE performance year to date is 3.97%. Today Pfizer Inc., PFE has gained -0.31%, with a current price of 32.66.
Ownership of the company is 0.04% for insider ownership while institutional ownership is 71.80%. The management of the company have seen the company have a payout ratio of 101.70%. Return of assets are at 4.20%, with return on investment at 7.30%.
In terms of debt levels and profit levels, Pfizer Inc., PFE is seeing a long-term debt/equity of 0.49. While Total debt/equity is 0.7. With a profit margin of 13.40%, this is combined with a gross margin of 77.80%, and operating margin of 17.60%. Pfizer Inc. ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 1.1.
For the last year Pfizer Inc., PFE has seen a EPS growth of -21.50%. A performance for the year of -0.73%. The 52-week high is -11.92%, and the 52-week low is 17.62%. The average volume for Pfizer Inc., PFE is 15568962.
With a target price of 39.4, can Pfizer Inc., PFE reach this target? Looking at the value indicators of Pfizer Inc., PFE. Pfizer Inc. has a P/E of 28.98 and a forward P/E of 12.3. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.44. Pfizer Inc. also has a P/S and a P/B of 3.8 and 3.16 respectively. For P/cash, Pfizer Inc. has a value of 9.49, while it is 32.84 for P/free cash flow.
At the current price of 32.66, Pfizer Inc. has a dividend yield of 3.67%. We see a return on equity of 10.90%.
Looking more long-term Pfizer Inc., is projected to get an EPS growth for the next five years of 6.52%. In the short-term an EPS growth of 8.06% in the next year is forecasted. This is after a EPS growth of -21.50% for this year and for the last five years a 1.60% growth has been seen.